BG109430A - FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTION - Google Patents
FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTIONInfo
- Publication number
- BG109430A BG109430A BG109430A BG10943006A BG109430A BG 109430 A BG109430 A BG 109430A BG 109430 A BG109430 A BG 109430A BG 10943006 A BG10943006 A BG 10943006A BG 109430 A BG109430 A BG 109430A
- Authority
- BG
- Bulgaria
- Prior art keywords
- fluconazole
- capsules
- improved release
- active ingredient
- fluconazole capsules
- Prior art date
Links
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 title abstract 4
- 229960004884 fluconazole Drugs 0.000 title abstract 4
- 239000002775 capsule Substances 0.000 title abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 241001508691 Martes zibellina Species 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 230000005660 hydrophilic surface Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0302030A HU227142B1 (en) | 2003-07-02 | 2003-07-02 | Capsule of improved release containing fluconazole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG109430A true BG109430A (en) | 2006-11-30 |
Family
ID=89981480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG109430A BG109430A (en) | 2003-07-02 | 2006-02-02 | FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTION |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1648451A2 (sk) |
| CN (1) | CN1812783A (sk) |
| BG (1) | BG109430A (sk) |
| CZ (1) | CZ200657A3 (sk) |
| EA (1) | EA008585B1 (sk) |
| HU (1) | HU227142B1 (sk) |
| PL (1) | PL380995A1 (sk) |
| SK (1) | SK50132006A3 (sk) |
| UA (1) | UA82532C2 (sk) |
| WO (1) | WO2005002553A2 (sk) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| GB0900786D0 (en) * | 2009-01-19 | 2009-03-04 | Natracine Uk Ltd | Therapeutic compositions |
| MD3971C2 (ro) * | 2009-04-29 | 2010-06-30 | Дмитрий СКУРТУ | Scaun-trenajor |
| EP2736495B1 (en) | 2011-07-29 | 2017-08-23 | Grünenthal GmbH | Tamper-resistant tablet providing immediate drug release |
| SI2736497T1 (sl) | 2011-07-29 | 2017-12-29 | Gruenenthal Gmbh | Tableta, odporna proti zlorabi, ki zagotavlja takojšnje sproščanje zdravila |
| JP6449871B2 (ja) | 2013-07-12 | 2019-01-09 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | エチレン−酢酸ビニルポリマーを含有する改変防止剤形 |
| CN105616378A (zh) * | 2014-10-31 | 2016-06-01 | 康普药业股份有限公司 | 一种氟康唑胶囊及其制备方法 |
| JP2018526414A (ja) | 2015-09-10 | 2018-09-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護 |
| CN113230236A (zh) * | 2021-04-29 | 2021-08-10 | 山东优杰生物科技有限公司 | 祛除灰指甲草本贴及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUT75616A (en) * | 1992-03-17 | 1997-05-28 | Pfizer | Method for prooucing porous delivery devices |
| US6214386B1 (en) * | 1995-11-22 | 2001-04-10 | Recordati, S.A. | Prompt-release oral pharmaceutical compositions for extemporaneous suspensions |
| EP1163234B1 (en) * | 1999-03-24 | 2005-10-26 | R.P. Scherer Technologies, Inc. | Pharmaceutical formulations with improved aqueous solubility |
| KR100694667B1 (ko) * | 1999-12-08 | 2007-03-14 | 동아제약주식회사 | 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제 |
| RU2201230C1 (ru) * | 2001-12-24 | 2003-03-27 | Закрытое акционерное общество "Брынцалов-А" | Лекарственное средство флузол, обладающее противогрибковым действием |
-
2003
- 2003-07-02 HU HU0302030A patent/HU227142B1/hu not_active IP Right Cessation
-
2004
- 2004-06-30 WO PCT/HU2004/000071 patent/WO2005002553A2/en active Application Filing
- 2004-06-30 EA EA200600085A patent/EA008585B1/ru not_active IP Right Cessation
- 2004-06-30 EP EP04743730A patent/EP1648451A2/en not_active Withdrawn
- 2004-06-30 CZ CZ20060057A patent/CZ200657A3/cs unknown
- 2004-06-30 UA UAA200600919A patent/UA82532C2/uk unknown
- 2004-06-30 PL PL380995A patent/PL380995A1/pl not_active IP Right Cessation
- 2004-06-30 SK SK5013-2006A patent/SK50132006A3/sk not_active Application Discontinuation
- 2004-06-30 CN CNA2004800184777A patent/CN1812783A/zh active Pending
-
2006
- 2006-02-02 BG BG109430A patent/BG109430A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1812783A (zh) | 2006-08-02 |
| CZ200657A3 (cs) | 2006-04-12 |
| PL380995A1 (pl) | 2007-04-16 |
| UA82532C2 (uk) | 2008-04-25 |
| HUP0302030A2 (hu) | 2005-03-29 |
| WO2005002553A3 (en) | 2005-03-24 |
| EA008585B1 (ru) | 2007-06-29 |
| WO2005002553A2 (en) | 2005-01-13 |
| SK50132006A3 (sk) | 2006-05-04 |
| EP1648451A2 (en) | 2006-04-26 |
| HU0302030D0 (en) | 2003-09-29 |
| HU227142B1 (en) | 2010-08-30 |
| EA200600085A1 (ru) | 2006-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG109430A (en) | FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTION | |
| MX2008012731A (es) | Tabletas de paracetamol de liberacion rapida. | |
| IL187475A (en) | A form of oral administration containing one population of micro-particles to release a variable of at least one active anesthetic and a second population of micro-particles containing at least one depressant and their use | |
| BRPI0414000B8 (pt) | composição farmacêutica sólida oral de liberação prolongada contendo tacrolimus na forma de uma dispersão sólida, forma de dosagem, e, uso da composição farmacêutica | |
| MY142067A (en) | Xanthine derivatives as selective hm74a agonists, processes for the manufacture of said derivatives, formulations comprising these derivatives, and their use in the treatment of diseases where under-activation of the hm74a receptor contributes to the disease | |
| WO2006124047A3 (en) | Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent | |
| EA200500909A1 (ru) | Модифицированное высвобождение фармацевтической композиции | |
| IL181524A (en) | Heterocyclic compounds, pharmaceuticals containing them and their use in the preparation of drugs | |
| IL184051A (en) | Acetylated GLP-1 compounds, containing and using pharmaceutical preparations | |
| AU2003274681A8 (en) | Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release | |
| TW200731971A (en) | Solid preparation | |
| IL181445A0 (en) | Use of (halobenzyloxy)benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium selective modulators | |
| EA201001083A1 (ru) | Композиция таблетки пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение | |
| WO2007008752A3 (en) | Sustained release pharmaceutical compositions for highly water soluble drugs | |
| HRP20090194T1 (en) | Dry granulated composition comprising emtricitabine and tenofovir df | |
| IL183357A0 (en) | Oral medicament for the modified release of at least one active principle, in multimicrocapsule form | |
| WO2008073282A3 (en) | Ph sensitive matrix formulation | |
| IL191758A0 (en) | Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof | |
| GB2443793B (en) | Product, method of manufacture and use | |
| WO2005007137A3 (de) | Ambroxolhaltige tabletten | |
| AR024564A1 (es) | Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico | |
| HK1120417A1 (en) | Stable nanoparticle formulations | |
| UA94220C2 (ru) | Композиция для косметического применения, которая содержит частички с захваченой водой и вещества, которые захватываются водочувствительными матрицами | |
| WO2011090725A3 (en) | Gastroretentive solid oral dosage forms with swellable hydrophilic polymer | |
| EP1680098A4 (en) | DELAYED RELEASE OF POSITIVELY-LOADED PHARMACOLOGICALLY EFFECTIVE MOLECULES FROM A POLYMER-CONTAINING MATRIX WITH POLARIZED OXYGENATOMES |